Innate Pharma (IPHA) Q1 2025 Earnings

27MarConfirmed
Q1 2024
Q1 2024
Q3 2024
Q1 2025
-0.45
-0.3
-0.15
0

Details

Expected EPS
-0.2639811
Actual EPS
-0.3209182
Surprise EPS
-0.06
Surprise Percent
+21.57%

Description

Innate Pharma (IPHA) has reported earnings of -0.3209182 per share for Q1 2025.

0 Comments

Share your thoughts